Saliva-derived components can enhance the performance of toluidine blue in photodynamic therapy
Results suggest that the use of histatin-enhanced PS offer a promising alternative to conventional PDT, potentially improving its outcomes.
Authors
- Ana Cláudia Pavarina (ORCID: https://orcid.org/0000-0002-9231-1994)
- Felipe Fornias Sperandio (ORCID: https://orcid.org/0000-0003-3134-7659)
- Walter L. Siqueira (ORCID: https://orcid.org/0000-0003-1921-3658)
- Luana Mendonça Dias (ORCID: https://orcid.org/0000-0002-5139-9715)
- Nicolas Macri
Institutions
- University of Saskatchewan (CA)
- Universidade Estadual Paulista (Unesp) (BR)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-02-13
- DOI
- https://doi.org/10.3389/fphar.2025.1538520
- Citations
- 1
- Primary Topic
- Photodynamic Therapy Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Canadian Institutes of Health Research
- Natural Sciences and Engineering Research Council of Canada